TENECTEPLASE - (First line)

Important: Therapy notes

Important: Formulation and dosage details

Formulation:

Injection 50mg (10,000 units) (hospital use only)

Dosage:

See ED Stroke thrombolysis pathway and Acute corononary syndrome guidance

ALTEPLASE

Important: Therapy notes

Important: Formulation and dosage details

Formulation:

Injection 10mg (5·8 million units/vial), 20mg (11·6 million units/vial), 50mg (29 million units/vial) (hospital use only)

Dosage:

Hyper-acute stroke presenting within 4·5 hours of onset of symptoms: refer to ED Stroke thrombolysis pathway
Pulmonary embolism and empyema [off-label]: See Allergic emergencies.

UROKINASE

Important: Therapy notes

Important: Formulation and dosage details

Formulation:

Injection 10,000 units, 25,000 units, 100,000 units (hospital use only)

Editorial Information

Document Id: F059